Hot Features
プレミアム
Biogen Inc (BIIB)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Mr. Adam KeeneyExec. VP & Head of Corporate Development | -455.00 | 85.11k | Derivative Exercise and Sale | 187.06 | 6.37k | - |
| 2026-05-01 | Mr. Adam KeeneyExec. VP & Head of Corporate Development | 484.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.37k | 8.23% |
| 2026-04-01 | Mr. Sean GodboutVP, CAO & Global Corporate Controller | -54.00 | 9.92k | Derivative Exercise and Sale | 183.78 | 1.34k | - |
| 2026-04-01 | Mr. Sean GodboutVP, CAO & Global Corporate Controller | 127.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.34k | 10.45% |
| 2026-02-12 | Ms. Nicole MurphyExec. VP and Head of Pharmaceutical Operations & Technology | 3.00 | 585.11 | 買い | 195.04 | 19.61k | 0.02% |
| 2026-02-06 | Mr. Christopher A. ViehbacherPresident, CEO & Director | 13.48k | 0.00 | Derivative Exercise and Retained Stock | - | 29.92k | 81.99% |
| 2026-02-06 | Mr. Christopher A. ViehbacherPresident, CEO & Director | -10.98k | 2.21M | Derivative Exercise and Sale | 201.18 | 29.92k | - |
| 2026-02-06 | Dr. Priya SinghalExec. VP & Head of Development | 1.77k | 0.00 | Derivative Exercise and Retained Stock | - | 8.04k | 28.26% |
| 2026-02-06 | Dr. Priya SinghalExec. VP & Head of Development | -5.13k | 1.03M | Derivative Exercise and Sale | 199.83 - 201.18 | 8.04k | - |
| 2026-02-06 | Ms. Nicole MurphyExec. VP and Head of Pharmaceutical Operations & Technology | 5.39k | 0.00 | Derivative Exercise and Retained Stock | - | 19.61k | 37.87% |
| 2026-02-06 | Ms. Nicole MurphyExec. VP and Head of Pharmaceutical Operations & Technology | -3.34k | 671.74k | Derivative Exercise and Sale | 201.18 | 19.61k | - |
| 2026-02-06 | Ms. Robin C. KramerExec. VP & CFO | 3.46k | 0.00 | Derivative Exercise and Retained Stock | - | 11.47k | 43.19% |
| 2026-02-06 | Ms. Robin C. KramerExec. VP & CFO | -1.54k | 310.42k | Derivative Exercise and Sale | 201.18 | 11.47k | - |
| 2026-02-06 | Mr. Adam KeeneyExec. VP & Head of Corporate Development | 3.50k | 0.00 | Derivative Exercise and Retained Stock | - | 5.88k | 146.69% |
| 2026-02-06 | Mr. Adam KeeneyExec. VP & Head of Corporate Development | -1.58k | 318.47k | Derivative Exercise and Sale | 201.18 | 5.88k | - |
| 2026-02-06 | Mr. Rachid IzzarExec. VP and Head of Global Product Strategy & Commercialization | 4.85k | 0.00 | Derivative Exercise and Retained Stock | - | 11.01k | 78.75% |
| 2026-02-06 | Mr. Rachid IzzarExec. VP and Head of Global Product Strategy & Commercialization | -2.04k | 410.00k | Derivative Exercise and Sale | 201.18 | 11.01k | - |
| 2026-02-06 | Dr. Jane GroganExec. VP & Head of Research | 2.27k | 0.00 | Derivative Exercise and Retained Stock | - | 4.06k | 126.58% |
| 2026-02-06 | Dr. Jane GroganExec. VP & Head of Research | -991.00 | 199.37k | Derivative Exercise and Sale | 201.18 | 4.06k | - |
| 2026-02-06 | Dr. Ginger GregoryExec. VP & Chief HR Officer | 4.59k | 0.00 | Derivative Exercise and Retained Stock | - | 22.36k | 25.86% |
| 2026-02-06 | Dr. Ginger GregoryExec. VP & Chief HR Officer | -2.59k | 520.86k | Derivative Exercise and Sale | 201.18 | 22.36k | - |
| 2026-02-06 | Mr. Sean GodboutVP, CAO & Global Corporate Controller | 720.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.22k | 145.45% |
| 2026-02-06 | Mr. Sean GodboutVP, CAO & Global Corporate Controller | -359.00 | 72.22k | Derivative Exercise and Sale | 201.18 | 1.22k | - |
| 2026-02-06 | Ms. Susan H. Alexanderインサイダー | 5.54k | 0.00 | Derivative Exercise and Retained Stock | - | 61.89k | 9.84% |
| 2026-02-06 | Ms. Susan H. Alexanderインサイダー | -3.50k | 704.93k | Derivative Exercise and Sale | 201.18 | 61.89k | - |
| 2026-01-30 | Dr. Priya SinghalExec. VP & Head of Development | 499.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.27k | 8.65% |
| 2026-01-30 | Dr. Priya SinghalExec. VP & Head of Development | -1.33k | 238.81k | Derivative Exercise and Sale | 179.30 - 179.89 | 6.27k | - |
| 2025-12-01 | Mr. Christopher A. ViehbacherPresident, CEO & Director | 3.64k | 0.00 | Derivative Exercise and Retained Stock | - | 16.44k | 28.39% |
| 2025-12-01 | Mr. Christopher A. ViehbacherPresident, CEO & Director | -3.40k | 605.16k | Derivative Exercise and Sale | 177.78 | 16.44k | - |
| 2025-10-31 | Dr. Jane GroganExec. VP & Head of Research | 358.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.79k | 24.98% |
| 2025-10-31 | Dr. Jane GroganExec. VP & Head of Research | -337.00 | 51.99k | Derivative Exercise and Sale | 154.27 | 1.79k | - |
| 2025-10-02 | Mr. Sean GodboutVP, CAO & Global Corporate Controller | 18.00 | 0.00 | Derivative Exercise and Retained Stock | - | 495.00 | 3.77% |
| 2025-10-02 | Mr. Sean GodboutVP, CAO & Global Corporate Controller | -8.00 | 1.24k | Derivative Exercise and Sale | 155.25 | 495.00 | - |
| 2025-08-29 | Dr. Priya SinghalExec. VP & Head of Development | 345.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.77k | 6.36% |
| 2025-08-29 | Dr. Priya SinghalExec. VP & Head of Development | -1.32k | 175.75k | Derivative Exercise and Sale | 132.22 - 133.55 | 5.77k | - |
| 2025-07-08 | Mr. Rachid IzzarExec. VP and Head of Global Product Strategy & Commercialization | -2.22k | 300.11k | 売り | 135.00 | 6.33k | -25.99% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
